Semnur Pharmaceuticals, Inc. (SMNR) › RevenueSemnur Pharmaceuticals, Inc. (SMNR) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2024$50.00M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share